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Background: Toxicological studies have raised concerns regarding the neurotoxic effects of per- and poly
fluoroalkyl substances (PFAS). However, observational evidence from human studies investigating the associa
tion between childhood PFAS and neurobehavior is limited and remains unclear.
Objectives: To examine whether childhood PFAS concentrations are associated with neurobehavior in children at
age 8 years and whether child sex modifies this relationship.
Methods: We used data from 208 mother-child dyads in the Health Outcomes and Measures of the Environment
(HOME) Study, a prospective pregnancy and birth cohort (Cincinnati, OH, USA). We quantified PFAS in child
serum at 3 and 8 years. We assessed neurobehavioral domains using the Behavior Assessment System for
Children-2 at 8 years. We used multiple informant models to estimate score changes per ln-increase in repeated
PFAS concentrations.
Results: Childhood PFAS were not associated with Externalizing or Internalizing Problems at 8 years. However,
we noted effect measure modification by sex, with higher scores in Externalizing Problems among males per lnunit increase in perfluorononanoate (PFNA) at 3 years (β = 4.3 points, 95% CI: 1.0, 7.7) while females had lower
scores (β = − 2.8 points, 95% CI: − 4.7, − 1.0). More Internalizing Problems were observed among males per lnunit increase in concurrent PFNA concentrations (β = 3.7 points, 95% CI: 0.7, 6.8), but not in females (β = − 1.7
points, 95% CI: − 4.6, 1.2). Childhood PFNA concentrations were associated with lower scores for attention
problems and activity of daily living.
Conclusion: While findings do not consistently support an association between childhood PFAS serum concen
trations and neurobehavior, child sex may play a role in this relationship.

Keywords:
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Externalizing problems
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1. Introduction
Per- and polyfluoroalkyl substances (PFAS) are a class of environ
mentally persistent man-made chemicals that have both hydro- and
lipophilic properties, making them highly desirable for commercial and

industrial uses as surfactants, emulsifiers, and performance chemicals,
such as hydraulic fluid and fuel additives. PFAS, which are chemically
stable due to the strong C–F bond, are highly resistant to biological,
chemical, and thermal degradation. PFAS are ubiquitous pollutants that
have been detected in environmental media, wildlife species, and
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human tissues (Lau et al., 2007). Data from the National Health and
Nutrition Examination Survey (NHANES) show that median concen
trations of serum perfluorooctanoate (PFOA), perfluorooctane sulfonate
(PFOS), perfluorohexane sulfonate (PFHxS), and perfluorononanoate
(PFNA) have declined among the US population (Dong et al., 2019).
However, PFAS remain a public health concern because of mounting
evidence linking them with cardiovascular disease, immunosuppression,
and neurodevelopment (Bach et al., 2016; DeWitt et al., 2018; Liew
et al., 2018; Rappazzo et al., 2017; Sunderland et al., 2019).
PFAS can disrupt thyroid hormone levels, alter neural cell differen
tiation, disturb neurochemical signaling and homeostasis, alter the
susceptibility of the cholinergic system, stimulate neuronal cell
apoptosis, and induce the formation of reactive oxidative stress (Bernt
sen et al., 2017; Eggers Pedersen et al., 2015; Johansson et al., 2009;
Johansson et al., 2008; Lee and Viberg, 2013; Lee et al., 2016; Liu et al.,
2013; Liu et al., 2015; Long et al., 2013; Reistad et al., 2013; Slotkin
et al., 2008; Yu et al., 2016). Experimental studies in mice have reported
disturbances in cognition and behavior from PFAS exposures occurring
prenatally and neonatally (Fuentes et al., 2007; Johansson et al., 2009;
Johansson et al., 2008; Viberg et al., 2013). In epidemiological studies,
prenatal concentrations of PFAS have been associated with behavioral
problems in children in the INUENDO (Biopersistent organochlorines in
diet and human fertility) cohort (Hoyer et al., 2015), the Danish Na
tional Birth Cohort (DNBC) (Luo et al., 2020), the Health Outcomes and
Measures of the Environment (HOME) Study (Vuong et al., 2021), the
Upstate KIDS Study (Ghassabian et al., 2018), and in a Faroese cohort
(Oulhote et al., 2019). Comparatively, the number of epidemiological
studies investigating the potential role of childhood PFAS in neuro
behavior are limited and results have been inconsistent. Some epide
miological studies have reported childhood PFAS were associated with
behavioral problems in children (Gump et al., 2011; Oulhote et al.,
2019; Oulhote et al., 2016), while others have reported protective or
null associations (Stein et al., 2013, 2014). Further, findings regarding
the relationship between childhood PFAS with internalizing behaviors
and adaptive skills remains unclear (Oulhote et al., 2019; Oulhote et al.,
2016; Stein et al., 2014).
Our study objectives were to: 1) examine the relationship of repeated
measures of serum PFAS concentrations during childhood with neuro
behavioral domains assessed at age 8 years, identifying possible win
dows of susceptibility; 2) identify potential sexual dimorphism in these
associations; and 3) examine the persistence of our previously reported
adverse associations between prenatal PFAS and neurobehavior taking
into account childhood PFAS concentrations (Vuong et al., 2021).

2.2. Childhood serum PFAS concentrations
Our analysis focused on PFOA, PFOS, PFHxS, and PFNA. These PFAS
compounds were quantified in child sera collected at ages 3 (n = 146)
and 8 years (n = 193) using on-line solid-phase extraction coupled to
high-performance liquid chromatography-isotope dilution mass spec
trometry with established quality control procedures (Kato et al., 2011).
The limit of detection (LOD) was 0.1 ng/mL for all PFAS except PFOS,
which was 0.2 ng/mL. We detected the four PFAS in all samples
analyzed from HOME Study children aged 3 and 8 years.
2.3. Neurobehavioral assessment
We assessed neurobehavior in 8-year-old children by parent-report
using the Behavioral Assessment System for Children-2 (BASC-2) (Rey
nolds and Kamphaus, 2004). The BASC-2 yields four composite scales: 1)
Externalizing Problems, including hyperactivity, aggression, and
conduct problem subscales; 2) Internalizing Problems, including anxi
ety, depression, and somatization subscales; and 3) Adaptive Skills,
including adaptability, social skills, activity of daily living, and func
tional communication subscales; and 4) Behavioral Symptoms Index,
including Externalizing Problems, Internalizing Problems, and attention
problems, atypicality, and withdrawal subscales. All scales have a mean
of 50 ± 10, with higher scores indicating poorer functioning or more of
those behaviors. In contrast, for Adaptive Skills and its subscales, higher
scores indicate better functioning.
2.4. Statistical methods
We analyzed data using descriptive statistics; we used the Student ttest for continuous variables and X2 for comparison of categorical var
iables. To test the hypothesis that childhood PFAS concentrations are
associated with poorer neurobehavioral outcomes in children, we used
multiple informant models to estimate βs and 95% confidence intervals
(CIs) between repeated measures of ln-transformed PFAS at ages 3 and 8
years and neurobehavior at age 8 years (Sanchez et al., 2011). This
method utilizes a non-standardized version of generalized estimating
equations for parameter estimation with the incorporation of separate
linear regression models that are embedded into each set of estimating
equations for each time period of interest. Thus, this model is able to
incorporate repeated measures of PFAS concentrations during childhood
to determine whether associations between PFAS measurements and
BASC-2 scores differ by timing of measurement during childhood. To
determine whether there are susceptible periods of vulnerability, we
incorporated the interaction term between PFAS and age at measure
ment, with statistical significance considered present if p < 0.10.
Because some interaction terms had a p < 0.10, we presented age-atexposure-measurement-specific βs. Final models included covariates
based on findings from Kingsley et al. (2018). Maternal sociodemo
graphic and behavior factors included age, race/ethnicity, marijuana
use, depression at enrollment, use of vitamin supplements during
pregnancy, IQ, marital status, and whether the child was breastfed. We
also adjusted for maternal blood lead level (16 ± 3 weeks gestation),
maternal serum cotinine (16 ± 3 weeks gestation), household income,
child sex, and the Home Observation for Measurement of the Environ
ment (HOME) score at age 1 year, which is an assessment of how
nurturing the home environment is by measuring the quality and
quantity of encouragement and support for child development (Caldwell
and Bradley, 1984). We additionally adjusted for prenatal concentra
tions of BDE-47 in a sensitivity analysis to determine if our conclusions
remained the same.
Using generalized additive models, we tested for non-linear re
lationships between childhood PFAS concentrations and neurobehavior.
We estimated sex-specific associations for males and females using the 3way interaction term between PFAS (continuous), child sex (categori
cal), and visit at PFAS measurement (categorical), as well as all possible

2. Materials and methods
2.1. Study design and cohort
We used the HOME Study, a prospective pregnancy and birth cohort,
for the present study. Between March 2003 and February 2006, we
recruited pregnant women from the greater Cincinnati area that fulfilled
the following inclusion criteria: 1) ≥18 years of age; 2) 16 ± 3 weeks of
gestation; 3) residing in housing constructed before 1978; 4) receiving
and planning to continue prenatal care and deliver at one of the
collaborating obstetric practices; 5) HIV- status; and 6) not taking any
medications related to seizures, thyroid disorders, or chemotherapy/
radiation. A detailed description of the methodology for the HOME
Study is described by Braun et al. (2020, 2017). Of the 468 enrolled
women, 390 remained to deliver live singletons. We included in the
present study 208 participants for whom information was available for
at least one PFAS measurement during childhood and a neurobehavioral
assessment at age 8 years. The study protocol was approved by the
Institutional Review Board (IRB) at the Cincinnati Children’s Hospital
Medical Center (CCHMC). The Centers for Disease Control and Preven
tion (CDC) and collaborating institutions deferred to CCHMC IRB as the
IRB of record.
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2-way interactions (PFAS×child sex, PFAS×visit, visit×child sex), with
a p < 0.10 indicating that statistically significant effect measure modi
fication by child sex was present. Finally, we adjusted for prenatal PFAS
concentrations to test whether associations differed between childhood
PFAS and BASC-2 scores and to examine whether previous associations
reported between prenatal PFAS and neurobehavior remained after
taking into account childhood PFAS concentrations (Vuong et al., 2021).
For the secondary analyses, we re-examined the relationship be
tween childhood PFAS and BASC-2 outcomes using body burden as the
measure of exposure to account for the dynamic and complex uptake
and elimination of PFAS during childhood that are influenced by
collinear temporal changes, such as dilution due to physical growth.
PFAS body burdens at ages 3 and 8 years were calculated using the
formula: body burden (μg) = PFAS serum concentration (μg/mL) ×
volume of distribution (mL/kg bw) × body weight (kg) (Thompson
et al., 2010). We used PFAS serum concentrations measured at chil
dren’s ages 3 and 8 years. For volume of distribution, we used values
provided by Thompson et al. (2010) for PFOA (170 mL/kg bw) and PFOS
(230 mL/kg bw). For PFNA and PFHxS, volume distributions for PFOA
and PFOS were used, respectively. This substitution, which was based on
rodent studies, showed that the volume distributions of differing chain
length perfluoroalkyl carboxylic acids are within the same range
(Koponen et al., 2018). Childhood body weight (kg) was measured using

a scale at ages 3 and 8 years.
3. Results
3.1. Study participants
The majority of women in the HOME Study were non-Hispanic white
(59.4%), 25–34 years of age (57.5%), educated beyond a high school
degree (72%), married or living with a partner (73%), nonsmokers
(82.1%), and did not consume alcohol during pregnancy (55.1%)
(Table 1). We found that PFOA concentrations at ages 3 and 8 years were
significantly higher among children of mothers who were older, nonHispanic white, had minimal or mild depressive symptoms, were mar
ried or living with a partner, and who breastfed their child. PFOA con
centrations were additionally significantly higher among children from
households with annual incomes ≥$80,000 and HOME scores ≥40. We
also found significantly higher PFOS and PFHxS concentrations at ages 3
and 8 years among children from households with higher HOME scores
and with two parents. Externalizing Problems scores at age 8 years were
significantly higher among children of mothers who used marijuana
during pregnancy and who were moderately/severely depressed.

Table 1
Childhood serum concentrations of PFAS (ng/mL) and BASC-II scores [Mean(SD)] at 8 years in the HOME Study by various characteristics.
n
Overall

3 years (GM)

8 years (GM)

Externalizing Problems

PFOA

PFOS

PFHxS

PFNA

PFOA

PFOS

PFHxS

PFNA

5.4

6.6

1.9

1.4

2.4

3.9

1.4

0.8

50(10)

Age, years
<25
25–34
≥35

58
119
30

4.1*
5.7
6.1

5.2
7.0
6.9

1.3
2.1
1.9

1.1
1.5
1.4

2.0*
2.5
3.0

3.4
4.0
4.8

1.1*
1.5
1.3

0.6*
0.8
0.8

49(11)
50(9)
50(8)

Race/ethnicity
Non-Hispanic White
Non-Hispanic Black and Others

123
84

6.5*
3.9

8.1*
4.5

2.5*
1.1

1.6*
1.1

2.8*
2.0

1.5*
3.2

1.6*
1.1

0.8
0.7

50(9)
50(11)

Household income
<$40,000
$40,000–$79,999
≥$80,000

88
67
52

4.1*
5.9
6.8

5.0*
6.8
9.1

1.2*
2.1
2.9

1.2
1.5
1.5

2.1*
2.5
3.0

3.6*
3.8
4.6

1.2
1.4
1.6

0.7
0.8
0.9

51(11)
49(9)
49(8)

Maternal marijuana use
No
Yes

192
15

5.5*
3.7

6.7
4.6

2.0*
0.8

1.4
1.6

2.5
2.0

4.0*
3.0

1.4
1.1

0.8
0.8

49(9)*
57(12)

Maternal depression
Minimal or mild
Moderate or severe

185
20

5.6*
4.2

6.6
6.2

1.9
1.9

1.4
1.4

2.5*
2.0

4.0
3.1

1.4
1.1

0.8
0.7

49(9)*
56(11)

Maternal vitamin use
Daily
<Daily
Never

159
35
13

5.5*
5.8
3.2

6.8
6.3
4.1

2.0
1.8
1.2

1.4
1.3
1.6

2.5
2.4
2.2

4.0
3.5
3.5

1.4
1.5
0.9

0.8
0.8
0.8

49(10)
51(10)
54(7)

Marital status
Married or living with partner
Not married or living alone

151
56

5.9*
3.8

7.1*
4.9

2.1*
1.3

1.5
1.2

2.6*
2.0

4.2*
3.2

1.5*
1.1

0.8
0.7

49(9)
51(12)

HOME Score
≥40
35–39
<35

119
40
34

6.4*
3.9
3.8

8.0*
4.4
4.7

2.4*
1.4
1.0

1.6*
1.1
1.3

2.8*
1.9
2.2

4.3*
3.3
3.7

1.6*
1.2
1.1

0.8*
0.6
0.7

49(9)
52(12)
50(8)

Ever breastfed current child
No
Yes

40
166

3.8*
5.8

5.2
6.9

1.6
1.9

1.0*
1.5

2.0*
2.5

3.3*
4.0

1.1
1.4

0.7
0.8

50(10)
50(10)

Child Sex
Male
Female

93
115

5.1
5.6

6.1
7.0

1.7
2.0

1.3
1.5

2.3
2.5

3.8
4.0

1.3
1.4

0.7
0.8

51(10)
48(9)

Abbreviations: GM - geometric mean.
*
p < 0.05.
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3.2. Longitudinal trends of PFAS in childhood

Table 3
Estimated score differences (95% CIs) in BASC-2 Internalizing Problems scale
and subscales at age 8 years by a ln-unit increase in childhood serum PFAS (ng/
mL), HOME Study.a

The median serum concentrations of PFOS in HOME Study children
decreased from age 3 (6.2 ng/mL) to 8 years (3.6 ng/mL) (Supplemental
Fig. S1). In contrast, the median body burden of PFOS increased from
age 3 (21.5 μg) to 8 years (24.3 μg) (Supplemental Fig. S2). The serum
concentrations of PFHxS also increased (6.5 μg to 8.1 μg), while PFNA
concentrations were relatively stable (3.2 μg to 3.4 μg). However, serum
PFOA concentrations and body burdens both decreased from age 3 to 8
years (5.4 ng/mL to 2.4 ng/mL for serum concentrations; 13.3 μg to
11.6 μg for body burdens).

PFAS

PFOA
3 years
8 years
PFOS
3 years

3.3. Childhood serum PFAS and neurobehavior
Childhood serum PFAS concentrations were not statistically associ
ated with Externalizing or Internalizing Problems or their corresponding
subscales at age 8 years (Tables 2–3). While no relationship was
observed between PFAS and Behavior Symptoms Index, we did observe
a significant inverse association between PFNA concentrations at age 3
years and attention problems (Table 4). Associations between childhood
PFAS and Adaptive Skills were not statistically significant, with point
estimates close to the null (Table 5). We did, however, find one statis
tically significant inverse association between PFNA at age 8 years and
scores for activity of daily living (β = − 2.4 points, 95% CI: − 4.4, − 0.4),
indicating poorer abilities. Additional adjustment for prenatal BDE-47
resulted in similar conclusions (results not shown). No evidence of a
non-linear relationship between childhood PFAS and BASC-2 compos
ites were observed. All non-linearity p-values in generalized additive
models were ≥ 0.10 (results not shown).

8 years
PFHxS
3 years
8 years
PFNA
3 years
8 years

Internalizing Problems

Anxiety

Depression

Somatization

β
(95% CI)

β
(95% CI)

β
(95% CI)

β
(95% CI)

0.4
(− 2.1, 2.9)
− 0.7
(− 3.5, 2.0)

− 0.4
(− 3.0, 2.2)
− 1.1
(− 4.1, 1.9)

0.2
(− 2.3, 2.7)
− 0.2
(− 2.9, 2.6)

1.4
(− 1.2, 4.0)
− 0.3
(− 3.2, 2.6)

0.6
(− 1.5, 2.6)
0.2
(− 2.3, 2.7)

1.4
(− 0.9, 3.8)
− 0.2
(− 3.2, 2.8)

− 0.2
(− 2.1, 1.6)
0.7
(− 1.5, 3.0)

0.1
(− 2.2, 2.4)
− 0.1
(− 2.8, 2.7)

0.6
(− 0.6, 1.7)
0.2
(− 1.5, 1.9)

0.8
(− 0.6, 2.1)
0.3
(− 1.7, 2.3)

0.8
(− 0.4, 1.9)
0.4
(− 1.2, 1.9)

− 0.2
(− 1.7, 1.3)
− 0.3
(− 2.2, 1.6)

0.1
(− 2.3, 2.5)
0.7
(− 1.6, 3.0)

0.5
(− 1.8, 2.9)
0.1
(− 2.6, 2.7)

− 0.5
(− 2.4, 1.4)
1.0
(− 1.2, 3.2)

0.3
(− 2.2, 2.8)
0.7
(− 1.6, 3.0)

PFAS were ln-transformed.
a
Adjusted by maternal age, race/ethnicity, household income, maternal
marijuana use, maternal blood lead, maternal serum cotinine, maternal
depression, vitamin use during pregnancy, maternal IQ, marital status, Home
Observation for Measurement of the Environment Score, whether the child was
breastfed, and child sex.

3.4. Effect measure modification by child sex
Overall, our results did not suggest that child sex modified the re
lationships between childhood PFAS concentrations and Adaptive Skills
(Supplemental Table S1). However, for Externalizing Problems, we
noted significant modification by child sex with higher concentrations of
PFNA at age 3 years (interaction term: PFNA × visit3 years × child sex =

0.074) (Fig. 1). Significantly more externalizing behaviors were
observed among males (β = 4.3 points, 95% CI: 1.0, 7.7), while less
externalizing behaviors were noted among females (β = − 2.8 points,
95% CI: − 4.7, − 1.0) with higher serum PFNA concentrations at age 3

Table 2
Estimated score differences (95% CIs) in BASC-2 Externalizing Problems scale and subscales at age 8 years by a ln-unit increase in childhood serum PFAS (ng/mL),
HOME Study.a
PFAS

PFOA
3 years
8 years
PFOS
3 years
8 years
PFHxS
3 years
8 years
PFNA
3 years
8 years

Externalizing Problems

Hyperactivity

Aggression

Conduct problems

β
(95% CI)

β
(95% CI)

β
(95% CI)

β
(95% CI)

0.1
(− 2.7, 2.8)
0.2
(− 2.8, 3.1)

− 0.4
(− 3.3, 2.6)
− 0.3
(− 3.4, 2.8)

− 0.2
(− 2.8, 2.4)
− 0.2
(− 3.1, 2.7)

0.7
(− 2.0, 3.5)
1.0
(− 2.4, 4.4)

− 1.3
(− 3.5, 1.0)
− 1.4
(− 4.1, 1.3)

− 1.2
(− 3.4, 1.1)
− 1.8
(− 4.7, 1.0)

− 1.0
(− 3.4, 1.5)
− 1.6
(− 4.2, 0.9)

− 1.2
(− 3.4, 1.1)
− 0.2
(− 3.1, 2.7)

0.02
(− 1.6, 1.6)
− 1.1
(− 2.8, 0.6)

− 0.3
(− 1.9, 1.2)
− 1.9
(− 3.9, 0.04)

0.1
(− 1.5, 1.7)
− 1.2
(− 2.9, 0.5)

0.4
(− 1.3, 2.1)
0.1
(− 1.9, 2.1)

− 0.7
(− 2.5, 1.1)
− 0.03
(− 1.9, 1.9)

− 0.8
(− 2.5, 0.9)
0.8
(− 1.4, 3.0)

− 0.7
(− 2.6, 1.2)
− 0.9
(− 3.0, 1.1)

− 0.4
(− 2.2, 1.4)
− 0.003
(− 2.2, 2.1)

PFAS were ln-transformed.
a
Adjusted by maternal age, race/ethnicity, household income, maternal marijuana use, maternal blood lead, maternal serum cotinine, maternal depression, vitamin
use during pregnancy, maternal IQ, marital status, Home Observation for Measurement of the Environment Score, whether the child was breastfed, and child sex.
4
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Table 4
Estimated score differences (95% CIs) in BASC-2 Behavior Symptoms Index and subscales at age 8 years by a ln-unit increase in childhood serum PFAS (ng/mL), HOME
Study.a
PFAS

Behavior Symptoms Index

Atypicality

Withdrawal

Attention problems

β
(95% CI)

β
(95% CI)

β
(95% CI)

β
(95% CI)

0.3
(− 2.4, 3.0)
0.4
(− 2.5, 3.2)

0.3
(− 2.4, 3.1)
0.04
(− 3.2, 3.3)

1.9
(− 0.8, 4.6)
2.1
(− 1.1, 5.3)

− 0.2
(− 3.2, 2.9)
0.7
(− 2.8, 4.2)

− 0.7
(− 2.7, 1.3)
− 0.3
(− 2.8, 2.2)

− 0.1
(− 2.0, 1.7)
0.2
(− 2.1, 2.4)

1.1
(− 1.2, 3.3)
1.0
(− 1.7, 3.7)

− 1.9
(− 4.1, 0.3)
0.2
(− 2.9, 3.3)

0.2
(− 1.0, 1.5)
− 0.8
(− 2.5, 0.8)

− 0.3
(− 1.4, 0.7)
− 1.3
(− 2.8, 0.2)

0.9
(− 0.6, 2.4)
0.6
(− 1.5, 2.7)

− 0.1
(− 1.6, 1.4)
− 0.5
(− 2.5, 1.4)

− 1.1
(− 2.9, 0.7)
0.5
(− 1.6, 2.6)

− 0.5
(− 2.1, 1.1)
− 0.1
(− 2.1, 2.0)

− 0.5
(− 2.8, 1.9)
0.5
(− 2.2, 3.3)

− 1.8
(− 3.4, − 0.2)
1.4
(− 0.8, 3.6)

PFOA
3 years
8 years
PFOS
3 years
8 years
PFHxS
3 years
8 years
PFNA
3 years
8 years

PFAS were ln-transformed.
a
Adjusted by maternal age, race/ethnicity, household income, maternal marijuana use, maternal blood lead, maternal serum cotinine, maternal depression, vitamin
use during pregnancy, maternal IQ, marital status, Home Observation for Measurement of the Environment Score, whether the child was breastfed, and child sex.
Table 5
Estimated score differences (95% CIs) in BASC-2 Adaptive Skills and its subscales at age 8 years by a ln-unit increase in childhood serum PFAS (ng/mL), HOME Study.a
PFAS

PFOA
3 years
8 years
PFOS
3 years
8 years
PFHxS
3 years
8 years
PFNA
3 years
8 years

Adaptive Skills

Adaptability

Social skills

Activity of daily living

Functional communication

β
(95% CI)

β
(95% CI)

β
(95% CI)

β
(95% CI)

β
(95% CI)

− 0.8
(− 3.7, 2.1)
− 1.2
(− 4.7, 2.2)

− 1.0
(− 4.3, 2.3)
− 0.3
(− 3.9, 3.2)

− 2.3
(− 5.4, 0.8)
− 1.3
(− 5.1, 2.4)

− 1.2
(− 4.1, 1.8)
− 2.1
(− 5.3, 1.2)

2.1
(− 1.0, 5.2)
0.3
(− 3.2, 3.7)

0.7
(− 1.5, 2.9)
− 2.2
(− 5.1, 0.6)

1.1
(− 1.2, 3.4)
− 0.1
(− 3.1, 2.9)

− 0.02
(− 2.5, 2.5)
− 2.5
(− 5.7, 0.6)

1.1
(− 1.3, 3.4)
− 1.4
(− 4.2, 1.4)

0.8
(− 1.3, 2.9)
− 1.8
(− 4.4, 0.8)

0.4
(− 1.1, 1.8)
0.1
(− 1.7, 1.9)

0.5
(− 1.0, 2.0)
0.8
(− 1.0, 2.5)

0.9
(− 0.7, 2.5)
0.9
(− 1.3, 3.1)

0.2
(− 1.4, 1.7)
0.1
(− 1.8, 2.1)

0.7
(− 0.7, 2.1)
0.2
(− 1.5, 1.9)

0.7
(− 1.3, 2.6)
− 2.1
(− 4.3, 0.1)

− 0.02
(− 1.9, 1.9)
− 1.6
(− 3.9, 0.7)

0.4
(− 1.6, 2.5)
− 1.8
(− 4.1, 0.6)

0.9
(− 1.3, 3.1)
− 2.4
(− 4.4, − 0.4)

0.9
(− 0.9, 2.7)
− 1.7
(− 4.0, 0.6)

PFAS were ln-transformed.
a
Adjusted by maternal age, race/ethnicity, household income, maternal marijuana use, maternal blood lead, maternal serum cotinine, maternal depression, vitamin
use during pregnancy, maternal IQ, marital status, Home Observation for Measurement of the Environment Score, whether the child was breastfed, and child sex.

years. In addition, concurrent PFOA was associated with higher
aggression scores in males (β = 2.7 points, 95% CI: − 0.7, 6.2), but lower
scores in females (β = − 3.4 points, 95% CI: − 7.5, 0.7) (interaction term:
PFOA × visit8 years × child sex = 0.051), albeit sex-stratified associations
were not statistically significant. We also observed effect modification
by sex with concurrent PFNA concentrations, with significantly higher
internalizing behaviors and depression scores among males (Internal
izing Problems: β = 3.7 points, 95% CI: 0.7, 6.8; Depression: β = 5.1

points, 95% CI: 2.5, 7.7), while there were null associations among fe
males (Internalizing Problems: β = − 1.7 points, 95% CI: − 4.6, 1.2;
Depression: β = − 2.1 points, 95% CI: − 4.8, 0.6). Similar findings were
also noted between PFNA and PFOA at age 8 years and Behavior
Symptoms Index (Supplemental Fig. S3).
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Fig. 1. Estimated score differences and 95% CIs in BASC-2 scores at age 8 years by a ln-unit increase in child serum PFAS concentrations (ng/mL) by child sex, HOME
Study. Adjusted by maternal age, race/ethnicity, household income, maternal marijuana use, maternal blood lead, maternal serum cotinine, maternal depression,
vitamin use during pregnancy, maternal IQ, marital status, Home Observation for Measurement of the Environment Score, and whether the child was breastfed.

3.5. Childhood body burden of PFAS and neurobehavior

and between the body burden of PFOS at age 3 years and attention
problems (Supplemental Table S5). We observed several significant sex
interactions among associations between PFAS body burden and neu
robehavior that were previously noted in our analyses of PFAS serum
concentrations, including effect measure modification by sex in the as
sociations between: 1) PFOA at age 8 years and aggression; 2) PFNA at
age 8 years and Internalizing Problems and depression; and 3) PFOA at
age 8 years and atypicality (Supplemental Table S6).

Childhood body burdens of PFAS were not associated with Exter
nalizing Problems (Supplemental Table S2). However, there was a sta
tistically significant inverse relationship between body burdens of
PFHxS at age 8 years and hyperactivity (β = − 2.1 points, 95% CI: − 3.9,
− 0.4) that was not present when we examined serum PFHxS. We
observed comparable associations between body burden of PFAS and
Internalizing Problems and Adaptive Skills as with PFAS serum con
centrations (Supplemental Tables S3–4). However, there were two
additional statistically significant inverse associations, specifically be
tween the body burden of PFHxS at age 8 years and atypicality scores

3.6. Prenatal and childhood PFAS and neurobehavior
We observed no relationship between prenatal PFAS concentrations
6
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4. Discussion

Estimated Score Difference (95% CI)

Estimated Score Difference (95% CI)

and Adaptive Skills in models adjusted for childhood PFAS concentra
tions (Supplemental Table S7). However, we continued to observe an
inverse relationship between PFNA at 8 years and activity of daily living.
There were several positive associations between prenatal PFAS and
Externalizing Problems after adjusting for childhood concentrations
(Fig. 2). Prenatal PFOS (β = 3.2 points, 95% CI: 1.0, 5.3), PFHxS (β = 2.1
points, 95% CI: 0.6, 3.7), and PFNA (β = 3.7 points, 95% CI: 1.1, 6.3)
were significantly associated with higher scores on Externalizing Prob
lems. These findings are concordant with those previously reported in
the HOME Study that did not take into account childhood PFAS con
centrations (Vuong et al., 2021). Statistically significant positive asso
ciations were also observed between prenatal PFOS, PFHxS, and PFNA
with hyperactivity, aggression, and conduct problems. Adjusting for
prenatal PFAS resulted in similar null associations between childhood
PFAS and Externalizing Problems. Finally, mutual adjustment for pre
natal and childhood PFAS resulted in significantly higher scores for
Internalizing Problems, somatization, Behavior Symptoms Index, and
attention problems in children with increased prenatal PFHxS (Supple
mental Table S8–9). We also continued to observe null findings between
childhood PFAS with Internalizing Problems and its subscales (Supple
mental Table S8) as well as a significant inverse relationship between
PFNA at 3 years with attention problems (Supplemental Table S9).

In this prospective cohort study, we observed that childhood serum
concentrations of PFAS at ages 3 and 8 years were not associated with
externalizing or internalizing behaviors in children at age 8 years.
However, there is suggestive evidence that child sex modifies the asso
ciations between childhood PFAS and neurobehavior, where higher
serum concentrations of PFOA and PFNA are associated with more
externalizing problems, internalizing problems, and behavior symptoms
in males compared to females. We also noted significant associations
between PFNA and lower scores for activity of daily living and attention
problems, though findings do not suggest childhood serum concentra
tions of PFOA, PFOS, or PFHxS are associated with behavior symptoms
or adaptive skills. Lastly, prenatal PFAS concentrations remain associ
ated with more externalizing and internalizing problems in children
even after taking into account childhood concentrations.
Our null findings between childhood PFAS and behavioral problems
are not consistent with the findings from the Faroese cohort (Oulhote
et al., 2019; Oulhote et al., 2016). PFNA concentrations at age 5 years
were significantly associated with more externalizing problems in chil
dren at age 7 years (Oulhote et al., 2016). Oulhote et al. (2016) also
reported more internalizing problems in children at 7 years with higher
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Fig. 2. Estimated score differences (95% CIs) in BASC-2 Externalizing Problems scale and subscales at age 8 years by a ln-unit increase in serum PFAS during
gestation and childhood (ng/mL), HOME Study. Adjusted by maternal age, race/ethnicity, household income, maternal marijuana use, maternal blood lead, maternal
serum cotinine, maternal depression, vitamin use during pregnancy, maternal IQ, marital status, Home Observation for Measurement of the Environment Score,
whether the child was breastfed, and child sex.
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PFOA serum concentrations at age 5 years. In the examination of early
life exposures to chemical mixtures, PFNA concentrations at 5 years was
significantly associated with higher total Strengths and Difficulties
Questionnaire (SDQ) scores, indicating worse behavioral problems
(Oulhote et al., 2019). However, no relationship was noted between
concurrent PFAS concentrations and behavioral problems at 7 years
(Oulhote et al., 2016). In a cross-sectional study examining serum PFAS
at age 10 years, higher concentrations of several PFAS were associated
with shorter inter-response times, indicating impulsivity (Gump et al.,
2011). In contrast, the C8 Health Study reported mixed findings, with
protective and null associations between childhood PFAS and behav
ioral problems, including inattention and impulsivity (Stein et al., 2013,
2014). The only adverse relationship observed in the HOME Study was
between prenatal PFAS and externalizing and internalizing behaviors,
which was previously reported by Vuong et al. (2021) and replicated in
the current study after taking into account childhood concentrations.
Our findings align with those from the INUENDO cohort examining
prenatal PFAS concentrations (Hoyer et al., 2015), but they contrast
with the protective associations reported in the Taiwanese and Danish
cohorts (Fei and Olsen, 2011; Lien et al., 2016) and the null associations
in the Dutch cohort (Quaak et al., 2016).
No other study has formally examined childhood PFAS and Adaptive
Skills using BASC-2, but a few have investigated aspects of this behav
ioral domain, including peer-social behaviors and self-help. Those
studies, which mainly focused on PFAS during gestational development,
mirror the results of the present study (Chen et al., 2013; Fei et al., 2008;
Goudarzi et al., 2016; Oulhote et al., 2016). In contrast, Lien et al.
(2016) observed better prosocial behavior and fewer peer problems in
children at 7 years with increased cord PFOA concentrations. Hoyer
et al. (2015) reported worse scores on the SDQ in children 7–9 years of
age with higher prenatal PFOA and PFOS concentrations. Our study
similarly lacked convincing evidence of a relationship between child
hood PFAS and Adaptive Skills. This finding is inconsistent with the
Faroese cohort where higher PFOA concentrations at age 5 years were
associated with problems with peer relationship, though further
adjustment for prenatal PFAS resulted in null associations (Oulhote
et al., 2016).
Our main findings on childhood PFAS concentrations and neuro
behavior were discordant with those of the Faroese cohort (Oulhote
et al., 2019; Oulhote et al., 2016). This discrepancy may relate to a
number of factors. In the Faroese study, PFAS serum concentrations
were measured at ages 5 and 7 years, while in the HOME Study con
centrations were measured at ages 3 and 8 years. In the Faroese study,
significant adverse associations were only noted between PFAS at 5
years, while null associations were observed with PFAS at 7 years with
behavioral outcomes. There were generally null findings in the present
study, though PFNA at 3 and 8 years was inversely associated with
attention problems and activity of daily living scores, respectively.
Inconsistent conclusions between the studies regarding the timing of
childhood PFAS exposure with neurobehavior does not indicate a spe
cific time period during childhood in which PFAS are more detrimental
to neurobehavior. Concentrations also differed between the cohorts,
with PFOS and PFOA median concentrations higher in Faroese children
at age 7 years (PFOS: 15.26 ng/mL; PFOA: 4.37 ng/mL) compared to
HOME Study children at age 8 years (PFOS: 3.6 ng/mL; PFOA: 2.4 ng/
mL). The administered neurobehavioral assessments also varied be
tween studies. We used the BASC-2, while Oulhote et al. (2019; 2016)
used the SDQ, which provides the scales of Externalizing Problems
(consisting of subscales: hyperactivity/inattention and conduct prob
lems) and Internalizing Problems (consisting of subscales: emotional
symptoms, peer relationship problems, and prosocial behavior). They
focused on subscales of the SDQ that pertained to adaptive skills,
including peer relationship problems and prosocial behavior, which may
have differed from our behavioral assessment of Adaptive Skills using
BASC-2. Lastly, statistical approaches varied between studies. While we
used multiple informant models that took into account repeated

measures of PFAS, Oulhote et al. (2016) used negative binomial
regression models. They did, however, used structural equation
modeling (SEM) as well as G-formula combined with Superlearner to
examine the joint associations between prenatal and childhood PFAS
along with other potential environmental contaminants (Oulhote et al.,
2019; Oulhote et al., 2016).
Interestingly, both the HOME Study and the Faroese cohort reported
potential sexual dimorphism between childhood PFAS and behavioral
domains. In the HOME Study, we noted more externalizing problems
with higher concentrations of PFNA at age 3 years and higher aggres
sions scores with increasing PFOA concentrations at age 8 years in
males, but not in females. In the Faroese cohort the opposite was found,
with female children appearing more sensitive to PFAS (Oulhote et al.,
2016). Higher PFOS, PFNA, and PFHXs concentrations at age 7 years
were associated with more externalizing problems, hyperactivity/inat
tention, and conduct problems in females, but not in males. It is unclear
as to why there is a discrepancy between the studies regarding effect
modification by sex results for childhood concentrations. While it re
mains to be determined whether males or females may be more sensitive
to PFAS’ potential neurotoxic effects, there is evidence from both studies
that the associations may differ by sex. The mechanisms that come into
play have yet to be elucidated, though eliminations rates between sexes
may contribute to sex-specific findings. Toxicological studies in mice
and rodents have shown differences in the clearance of PFAS by sex,
with PFOA, PFNA, and PFOS having longer half-lives in males because of
slower elimination rates (Kennedy Jr. et al., 2004; Ohmori et al., 2003;
Tatum-Gibbs et al., 2011). In humans, PFOS and PFHxS have also been
observed to have longer half-lives in males than in females (Li et al.,
2018).
The present study has several strengths, including prospective
childhood PFAS exposure assessment and extensive covariate informa
tion, including maternal depression, caregiving quality/quantity, and
measurements of other potential neurotoxicants. We had repeated
measurements of PFAS during childhood, and examined associations
taking into account prenatal PFAS concentrations. Third, we utilized
multiple informant models to identify potential windows of suscepti
bility. Lastly, we relied on the BASC-2 to assess neurobehavior in chil
dren, which is a reliable and valid neurobehavioral battery.
We also recognize some study limitations. First, the sample size
limits our power to examine effect measure modification by sex.
Although some findings would suggest potential sexual dimorphism, our
results should be interpreted cautiously given the sample size. Second,
while we had two serum PFAS measurements during childhood, earlier
measurements during infancy and around toddler age may be more
detrimental to neurodevelopment. Third, we do not have information
regarding water consumption sources or frequency within the HOME
Study for children at 3 and 8 years. Quantification of PFAS concentra
tions in child serum occurred after Cincinnati implemented water
treatment technology to remove PFAS. Given that the main route of
human exposure to PFAS is via water consumption and that 60% of
water volume consumed by US children 4–13 years is from tap water
sources, it is likely that our findings may be biased toward the null
(Drewnowski et al., 2013; Sunderland et al., 2019). Multiple compari
sons remains a potential concern despite the use of multiple informant
models to reduce the total number of models in the study because there
is no reduction in type 1 error. However, given our generally null as
sociations, type 1 error is not a serious concern. In addition, we did not
examine mixtures of PFAS, which may have additive, synergistic, or
negative effects. Lastly, findings may not be entirely generalizable as
some PFAS concentrations in the HOME Study are higher than those
reported in NHANES. While the geometric mean (GM) of PFOS con
centrations in HOME Study mothers (12.8 ng/mL) was comparable to
that of pregnant women in NHANES 2003–2004 (12.3 ng/mL), PFOA
concentrations are higher in the HOME Study (5.3 ng/mL compared to
2.39 ng/mL) (Woodruff et al., 2011). Childhood concentrations of PFOA
and PFOS were also higher in the HOME Study at 3 and 8 years
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compared to concentrations quantified in serum of children at 3–5 and
6–11 years in NHANES 2013–2014 (Ye et al., 2018).
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5. Conclusions
Findings from the HOME Study do not support a relationship be
tween childhood serum concentrations of four PFAS compounds and
neurobehavior. Nevertheless, there is some evidence to suggest that sex
may modify the relationship between childhood PFAS and neuro
behavior, with males being more sensitive to increasing concentrations
of PFOA and PFNA. The null association observed between PFAS con
centrations in all HOME Study children and BASC-2 outcomes may be
due to the inverse associations observed among females that attenuated
the positive associations in male children. However, because of our
limited sample size, results should be interpreted cautiously and repli
cated in sufficiently powered birth cohorts. Last, we also confirmed
previous findings from the HOME Study between higher prenatal PFAS
concentrations and more externalizing and internalizing problems in
children after taking into account childhood PFAS concentrations.
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